ChroMedX Corp. Engages Conductive Technologies Inc. for Biosensor Development Programme

April 20, 2016 4:30 PM

TORONTO, ON / ACCESSWIRE / April 20, 2016 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce the engagement of Conductive Technologies Inc. (CTI) of York, Pennsylvania to assist with biosensor development on the Company's HemoPalm technology. ChroMedX has previously reported on the collaboration with Polygenesis on the development of...

Read more

True Leaf Signs with Pet Food Experts to Distribute TRUE HEMP(TM) Dog Chews to 3500 Stores across the US

March 29, 2016 3:40 AM

VANCOUVER, BC / ACCESSWIRE / March 29, 2016 / True Leaf Medicine International (CSE: MJ) (FSE: TLA) has reached a significant milestone as a pioneering producer of hemp-based pet nutrition products by signing an agreement with Pet Food Experts, Inc., gaining distribution in the United States for the first time. To view an enhanced version of TRUE HEMP™ Pet Chews, please...

Read more

True Leaf Launches 'True Hemp' Pet Chews at US Debut

March 3, 2016 3:40 AM

VANCOUVER, BC / ACCESSWIRE / March 3, 2016 / A success wherever they're sold in Canada, True Leaf International Ltd.'s (CSE: MJ) (FSE: TLA) hemp-based chews for dogs will soon be available for sale in the United States - and the company is celebrating the occasion with a new name and new packaging for the US market. To view an enhanced version of TRUE HEMP™ Pet Chews, please visit:...

Read more

ChroMedX Corp. Extends Expiry Date of Certain Warrants

February 22, 2016 3:24 PM

TORONTO, ON / ACCESSWIRE / February 22, 2016 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2.F), a developer of in vitro diagnostics and point-of-care testing (POCT) announces that, in accordance with CSE policies, it intends to extend the expiry date of an aggregate of 8,572,500 previously issued warrants (the "Warrants"). The Warrants were originally issued between July 7, 2014 and September 22, 2014, with original expiry dates ranging...

Read more

True Leaf Increases Its "Pet Smarts" through Agreement with Pet Industry Experts

February 22, 2016 3:20 AM

VANCOUVER, BC / ACCESSWIRE / February 22, 2016 / True Leaf Medicine International Ltd. (CSE: MJ) (FRANKFURT: TLA) ("True Leaf" or the "Corporation") has signed a consulting services agreement (the "Agreement") with the consulting firm Pet Industry Experts LLC (PIE), headed by the founder of pet industry giant PetSmart ®. The purpose of this relationship is to bring additional expertise to True Leaf as it prepares to launch it hemp-based...

Read more

Gerald Thermos Files Patent Application

February 8, 2016 5:35 PM

LOS ANGELES, CA / ACCESSWIRE / February 8, 2016 / Gerald Thermos Invents 100% Polyurea Spray Coating Gerald Thermos a leader in the field of polyurea and polyurethane coatings, invents a 100% Polyurea Spray Coating. Gerald has over 25 years of experience in this field, and has even filed for a patent for the processing and use of a 100% polyurea elastomeric system. This invention has the potential to greatly improve the quality of polyureas...

Read more

True Leaf Expands its Retail Reach Across Canada

February 2, 2016 3:15 AM

VANCOUVER, BC / ACCESSWIRE / February 2, 2016 / True Leaf Medicine International Ltd. (CSE: MJ) ("the company") has extended its retail channels for its innovative hemp-based dog chews, effectively covering all 10 Canadian provinces and the three territories. The company has increased the number of stores in British Columbia, Alberta and Ontario, a 35% increase in its retail distribution network. At the same time, True Leaf has added e-commerce...

Read more

True Leaf Medicine Announces Close of Private Placement and Debt Conversion

January 19, 2016 9:45 AM

VANCOUVER, BC / ACCESSWIRE / January 19, 2016 / True Leaf Medicine International Ltd. (CSE: MJ) (the "Company"), is pleased to announce that it has closed a private placement of 2,005,953 units at a price of $0.105 per unit, yielding gross proceeds of $210,625 to be used to facilitate a move to a larger-scale manufacturing facility in Ontario, Canada and also for general working capital. Each unit is comprised of 1 common share and one-half of...

Read more

True Leaf Medicine International Ltd. Offers $225,000 Non Brokered Private Placement

January 4, 2016 9:38 AM

VANCOUVER, BC / ACCESSWIRE / January 4, 2016 / True Leaf Medicine International Ltd. (FSE: TLA.F) (CSE: MJ) has arranged a non-brokered private placement of up to 2.142.857 units at a subscription price of $0.10.5 per unit to eligible subscribers for gross proceeds of up to $225,000. Each unit will consist of one common share and one half-share purchase warrant. A whole warrant can be redeemed for one additional common share of the company at $...

Read more

ChroMedX Completes Proof-of-Concept CO-oximetry and Bilirubin Prototype Development

December 11, 2015 4:21 PM

TORONTO, ON / ACCESSWIRE / December 11, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) devices is pleased to report the development of a proof-of-concept prototype of the Company's HemoPalm(TM) analyzer and associated cartridge for measuring CO-oximetry and bilirubin*. The prototype analyzer uses the same light source and spectrophotometer that...

Read more

True Leaf Medicine International Inc.: Canada's Only Hemp Dog Chews are Selling Fast

December 9, 2015 3:20 AM

VANCOUVER, BC / ACCESSWIRE / December 9, 2015 / Canada's first and so far only hemp-based dog chews are already selling out in stores across Ontario and the West. Now, True Leaf Medicine International Inc. (FSE: TLA) (CSE: MJ) ("True Leaf" or "the Company") is moving to a manufacturer with greater capacity, in order to meet demand. Launched at the end of September, the first product run of the line of treats is on shelves in 35 stores in western...

Read more

ChroMedX Engages Hochuen International Corp. for Improved Prototype Cartridge Production

December 8, 2015 4:17 PM

TORONTO, ON / ACCESSWIRE / December 8, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report that it has engaged Hochuen International Corp. to produce an enhanced version of its prototype HemoPalm cartridges. ChroMedX Corp. has entered into a development agreement with Hochuen International Corp. to produce the enhanced version of...

Read more

QuantumSphere CEO to Present at the LD Micro Main Event

November 24, 2015 10:00 AM

SANTA ANA, CA / ACCESSWIRE / November 24, 2015 / QuantumSphere, Inc. (OTCQB: QSIM), a leading producer of advanced catalyst technologies for industrial chemical processes, announced today that it will be presenting at the 8th annual LD Micro Main Event. Kevin Maloney, Chief Executive Officer, will present QuantumSphere's business model and growth strategy at 11:00 a.m. on Wednesday, December 2, 2015 in Track 4. LD Micro Main Event takes place...

Read more

Trecora Resources to Present at the LD Micro Conference December 2 in Los Angeles

November 24, 2015 7:00 AM

SUGAR LAND, TX / ACCESSWIRE / November 24, 2015 / Trecora Resources (NYSE: TREC), a leading provider of high purity specialty hydrocarbons and waxes, is scheduled to present at the 8th Annual LD Micro Conference in Los Angeles on Wednesday, December 2, 2015, at the Luxe Sunset Hotel. Trecora's Chief Executive Officer, Simon Upfill-Brown, will present at noon Pacific Time and is available for one-on-one meetings that day. About LD Micro LD Micro...

Read more

True Leaf Medicine International Ltd. Enters into Loan Agreement with First Pacific Enterprises Inc.

November 2, 2015 11:06 PM

VANCOUVER, BC / ACCESSWIRE / November 2, 2015 / True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) has entered into a loan agreement with First Pacific Enterprises Inc. (the "Lender") whereby the Lender has agreed to lend True Leaf CAD $60,000 (the "Loan"). First Pacific Enterprises Inc. is owned by Darcy Bomford, True Leaf's CEO. The Loan will become due and repayable by the Borrower to the Lender on April 30, 2016 (the "Due Date"). The...

Read more

True Leaf Secures European Hemp Supply and is Poised to Bring True Love(TM), True Spirit(TM) and True Calm(TM) to Europe's $26 Billion Pet Market* in 2016

November 2, 2015 3:06 AM

VANCOUVER, BC / ACCESSWIRE / November 2, 2015 / True Leaf Medicine International Ltd. (CNSX: MJ) has entered into negotiations with a European co-packer manufacturer of pet products, secured a European supply of hemp and is reviewing prospective firms to represent the company in Europe. Mr. Narcisse Kayser, former international sales manager for ANF pet foods, has been hired by the company to help manage the initial European strategy. With three...

Read more

ChroMedX Corp. Announces Closing of First Tranche of Private Placement

October 16, 2015 6:48 PM

TORONTO, ON / ACCESSWIRE / October 16, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it has completed the first tranche of its previously announced non-brokered private placement (the "Offering"), pursuant to which the Company issued and sold an aggregate of 1,750,000 units (each, a "Unit") of the Company at a price of...

Read more

ChroMedX Corp. Awarded New United States Patent on Ultra Filtration Technology

October 14, 2015 4:15 PM

TORONTO, ON / ACCESSWIRE / October 14, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that the Company has been awarded a United States patent on its Ultra Filtration technology. ChroMedX was awarded US Pat. No. 9,162,186, entitled "Sample Filtration Assembly". This patent is related to manual ultrafiltration cartridges, and...

Read more

International Centre for Chemical Safety and Security and Chlorine Institute Sign MoU to Improve Chlor-alkali Safety and Stewardship

October 14, 2015 8:00 AM

WARSAW, POLAND and ARLINGTON, VA / ACCESSWIRE / October 14, 2015 / The International Centre for Chemical Safety and Security (ICCSS) and The Chlorine Institute (CI) signed a Memorandum of Understanding (MoU) to jointly upgrade practices and policies, develop and conduct training programs and voluntary initiatives, and share expertise and best practices to enhance chlor-alkali chemical safety, security and stewardship worldwide. ICCSS Board...

Read more

ChroMedX Corp. Announces Private Placement of Units

October 9, 2015 8:20 PM

TORONTO, ON / ACCESSWIRE / October 9, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering") for gross proceeds of up to CDN$800,000 through the issuance of up to 4,000,000 units (each a "Unit") at a price of CDN$0.20 per Unit. Each Unit will be comprised...

Read more